Clinical trial
The Perception of Celestamine Treatment in Mexico: a Retrospective Assessment of Consumer Perception of Prior Celestamine Use
NCT04645979 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Perception of Celestamine Treatment in Mexico: a Retrospective Assessment of Consumer Perception of Prior Celestamine Use
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 11, 2020
- Completion date
- November 27, 2020
- Enrollment
- 153 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.